pinocembrin has been researched along with Atrial Fibrillation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Liu, Z; Wan, W; Yang, B; Ye, T; Yu, Y; Zhang, C | 1 |
| Bo, Y; Cui, Z; Tianxin, Y; Weiguo, W; Yi, Y; Zhangchi, L | 1 |
| Liang, J; Liu, D; Liu, X; Wan, W; Wu, G; Yang, B; Ye, T; Zhang, C | 1 |
3 other study(ies) available for pinocembrin and Atrial Fibrillation
| Article | Year |
|---|---|
Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Caspase 1; Collagen Type I; Connexins; Disease Models, Animal; Fibrosis; Heart Atria; Inflammation; Ion Channels; Isoproterenol; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley | 2022 |
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction.
Topics: Animals; Atrial Fibrillation; Calcium Channels, L-Type; Cardiotonic Agents; Connexin 43; Cytokines; Flavanones; Heart Atria; Heart Rate; Male; Myocardial Infarction; NF-KappaB Inhibitor alpha; Rats, Sprague-Dawley; Transcription Factor RelA | 2019 |